Paul Thomas

Paul Thomas serves as the Chief Executive Officer of Prominex Inc., a company focused on developing Molecular Point-of-Care Testing solutions for infectious diseases since its founding in 2018. In addition, Paul holds board positions at AbioMed, Inc., Surgalign, and axogen, and previously served as a board director and founder at Roka Bioscience, which specializes in molecular diagnostics. Paul also has substantial leadership experience from stints as President, CEO, and Chairman of LifeCell Corporation, a pioneer in regenerative medicine, and as President/COO of OHMEDA PPD, a leader in anesthesia and critical care products. Paul Thomas holds an MBA in Marketing and Finance from Columbia University and has a strong academic background in Chemistry.